2020
DOI: 10.1101/2020.04.30.20085613
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

Humoral immune response and prolonged PCR positivity in a cohort of 1343 SARS-CoV 2 patients in the New York City region

Abstract: 2Background: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a 1 3 CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

Help me understand this report
View published versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

14
137
1
4

Year Published

2020
2020
2022
2022

Publication Types

Select...
5
4

Relationship

1
8

Authors

Journals

citations
Cited by 103 publications
(156 citation statements)
references
References 15 publications
14
137
1
4
Order By: Relevance
“…If detectable antibodies serve as a correlate of immunity, serological testing may be used to identify protected individuals (11). While our understanding of the immunological response to SARS-CoV-2 infection remains incomplete, the vast majority of individuals experience seroconversion after 20 infection (12) and convalescent plasma from recovered COVID-19 cases appears to improve outcomes in critically ill patients (13)(14)(15). Together, these data suggest that recovered individuals have some protection against subsequent reinfection.…”
Section: Main Textmentioning
confidence: 99%
See 1 more Smart Citation
“…If detectable antibodies serve as a correlate of immunity, serological testing may be used to identify protected individuals (11). While our understanding of the immunological response to SARS-CoV-2 infection remains incomplete, the vast majority of individuals experience seroconversion after 20 infection (12) and convalescent plasma from recovered COVID-19 cases appears to improve outcomes in critically ill patients (13)(14)(15). Together, these data suggest that recovered individuals have some protection against subsequent reinfection.…”
Section: Main Textmentioning
confidence: 99%
“…Given that the virus has only been circulating for a matter of months in 15 humans, both the duration of antibody protection and the extent to which those antibodies protect against future infections is unknowable. However, most individuals who are infected seroconvert (12), and ongoing studies of SARS-CoV-2 show that antibodies persist for at least 7 weeks (37). Third, we assume that antibodies detected by serology are a correlate of protection.…”
Section: Main Textmentioning
confidence: 99%
“…Since a considerable percentage of infections may be asymptomatic, increased testing approaches may be needed to detect these persons [6,7]. While Colombia has tested 36,855 per million people in a country with 50 million people, Brazil, with 330 million people have tested 62,202 individuals, and Peru and Chile are the countries with more tested people in South America, exceeding the 171,931 tests.…”
Section: Resultsmentioning
confidence: 99%
“…If a considerable percentage of infections are asymptomatic, increased testing approaches may be needed to detect these persons [6,7]. Colombia has tested 3,741 per million people in a country with 50 million people, Brazil, with 330 million people have tested 3,462 subjects, Peru and Chile are the countries with more tested people in South America, exceeding the 25,000 tests.…”
Section: Discussionmentioning
confidence: 99%